Biotechs Rev Up To Go Public, Spurring Hope For The Sector
A smattering of biotech companies have signaled plans to go public in recent days, kicking off what industry insiders expect to be a busy spring and summer for the public markets. Despite a rocky past few weeks for geopolitics, industry insiders are hopeful that 2026's initial public offering market could trigger a steady return to normalcy.
Doctors Hope Justices Maintain Shield Against Med Mal Suits
A case headed to the U.S. Supreme Court next week could roll back a legal doctrine that physicians say is key to protecting them from frivolous medical malpractice suits filed by patients who've already lost in state court.
3 Things To Know About Marine's Abortion Pill Discovery Row
A Marine pilot accused of duping a Texas woman with whom he had an intimate relationship into taking abortion pills by lacing her drink is now locked in a dogged discovery battle over the release of salacious text messages and is headed back to court Wednesday. Here, Law360 examines three things to know about the case ahead of the hearing.
Biotechs Rev Up To Go Public, Spurring Hope For The Sector
A smattering of biotech companies have signaled plans to go public in recent days, kicking off what industry insiders expect to be a busy spring and summer for the public markets. Despite a rocky past few weeks for geopolitics, industry insiders are hopeful that 2026's initial public offering market could trigger a steady return to normalcy.
Doctors Hope Justices Maintain Shield Against Med Mal Suits
A case headed to the U.S. Supreme Court next week could roll back a legal doctrine that physicians say is key to protecting them from frivolous medical malpractice suits filed by patients who've already lost in state court.
3 Things To Know About Marine's Abortion Pill Discovery Row
A Marine pilot accused of duping a Texas woman with whom he had an intimate relationship into taking abortion pills by lacing her drink is now locked in a dogged discovery battle over the release of salacious text messages and is headed back to court Wednesday. Here, Law360 examines three things to know about the case ahead of the hearing.
Expert Analysis
The policy landscape for peptides is undergoing a significant shift under the Trump administration, moving toward ... (more story)
A recent order from President Donald Trump establishing a federal taskforce for addressing fraud in federally fund... (more story)
Utah's new law requiring hospitals to implement comprehensive workplace violence reporting systems continues a bro... (more story)
Deals & Corporate Governance More
Venture-backed pre-clinical biotechnology firm CrossBridge Bio Inc., advised by Cooley LLP, on Tuesday announced that it has agreed to be bought by pharmaceutical giant Eli Lilly & Co. in a deal worth up to $300 million.
American Industrial Partners has agreed to acquire Avanos Medical Inc. in an all-cash transaction valued at nearly $1.3 billion, a take-private deal steered by three law firms, Avanos announced Tuesday.
The U.S. Chamber of Commerce and other business groups urged the U.S. Supreme Court to take up an appeal from Sanofi-Aventis, Eli Lilly, Novo Nordisk and AstraZeneca, arguing the Second Circuit's revival of an... (more story)
In this week's Taxation With Representation, Gilead Sciences Inc. acquires clinical-stage biotechnology company Tubulis GmbH, private equity firm Court Square Capital Partners closes a multibillion-dollar fund... (more story)
A Massachusetts federal judge has refused to let a Johnson & Johnson MedTech subsidiary dodge claims that it infringed a blood pump patent, the latest event in a wider legal battle launched against it by a uni... (more story)
A smattering of billion-dollar M&A transactions could be the kickoff of an exciting period for dealmaking.
Digital Health & Technology More
Two pharmacy benefit managers can't dodge an antitrust lawsuit accusing them of price-fixing reimbursement rates because Michigan has properly claimed an antitrust violation, state Attorney General Dana Nessel... (more story)
Applied Medical Resources Corp. has urged a California federal court to reject Medtronic Inc.'s attempt to ditch its roughly $382 million antitrust trial loss, arguing that Medtronic is simply repeating "erron... (more story)
An Inova Health Care Services patient is urging a Virginia federal judge to grant final approval to a $3.1 million deal to resolve claims the healthcare system unlawfully shared private health information with... (more story)
Less than a month ahead of trial, a New York fertility clinic has agreed to resolve a suit accusing it of negligently allowing a woman's eggs to be destroyed due to alleged mishandling, according to documents ... (more story)
Two attorneys looking to temporarily helm a series of putative data breach class actions targeting a radiology firm have failed to become interim co-lead class counsel, as a North Carolina Business Court judge... (more story)
Michigan's attorney general is urging a federal court to reject a renewed bid by pharmacy benefit managers to pause discovery in an antitrust case accusing them of price-fixing reimbursement rates, claiming th... (more story)
Policy & Compliance More
A split Fourth Circuit panel on Tuesday tossed a Maryland district court's order denying a preliminary injunction to pharmaceutical manufacturers that have challenged a state law addressing drug delivery in th... (more story)
A whistleblower who secured a $183 million trial win against Eli Lilly urged the U.S. Supreme Court on Tuesday to reject its constitutional challenge over his ability to sue for the federal government, arguing... (more story)
Colorado's justices pushed Children's Hospital Colorado on Tuesday to explain how its decision to halt gender-affirming care for transgender youth patients is not discriminatory, even amid the federal governme... (more story)
Pharmaceutical Research and Manufacturers of America claims a new Washington state law attempts to illegally reshape the federal 340B Drug Pricing Program and singles out participating drugmakers with burdenso... (more story)
Medical providers are urging a Georgia federal court to deny United's bid for an early win in its case seeking a declaration that the providers' purported attempt to claw back reimbursements for out-of-network... (more story)
The U.S. Food and Drug Administration on Tuesday issued draft guidance recommending steps drug companies should take to evaluate the safety of gene-editing technology as they seek federal approval for cutting-... (more story)